Anti-H can trigger apoptosis and down-regulate FUT1 expression in erythroid differentiated K562 cells without...

Area of Science:

• Transplantation Immunology
• Hematology
• Molecular Biology

Background:

• Delayed red blood cell (RBC) engraftment and pure red cell aplasia (PRCA) are complications in major ABO-incompatible hematopoietic stem cell transplantation (HSCT).
• The mechanisms underlying graft accommodation and the interaction of incompatible antibodies with graft antigens are not fully understood.
• Understanding these interactions is crucial for improving HSCT outcomes.

Purpose of the Study:

• To investigate the effects of anti-H antibodies on erythroid cells.
• To analyze the impact of anti-H on proliferation, apoptosis, and FUT1 gene expression in erythroid differentiated K562 cells.
• To explore potential mechanisms for graft accommodation in ABO-incompatible HSCT.

Main Methods:

• Erythroid differentiated K562 cells were treated with varying dilutions of anti-H antibodies.
• Cell proliferation was assessed using the MTT assay.
• Apoptosis was measured by Annexin V/PI staining, and FUT1 mRNA expression was quantified using RT-PCR, often under complement-free conditions.

Main Results:

• Anti-H significantly suppressed erythroid cell growth at dilutions ≤ 1:8.
• Anti-H significantly increased apoptosis at dilutions ≤ 1:16, demonstrating dose- and time-dependent effects.
• Anti-H suppressed FUT1 mRNA expression at dilutions ≤ 1:16, also showing dose- and time-dependent effects.

Conclusions:

• Anti-H antibodies can induce apoptosis and down-regulate FUT1 expression in erythroid cells independently of complement.
• These effects suggest a mechanism by which anti-H antibodies may facilitate graft accommodation by reducing ABH antigens.
• The findings provide insights into managing complications in ABO-incompatible HSCT.